First Line Camizestrant For Emerging The New England Journal Of
Jun 1 2025 nbsp 0183 32 Mutations in ESR1 are the most common mechanism of acquired resistance to treatment with an aromatase inhibitor plus a cyclin dependent kinase 4 and 6 CDK4 6 inhibitor for advanced breast cancer
Lepodisiran The New England Journal Of Medicine, Mar 30 2025 nbsp 0183 32 Elevated lipoprotein a concentrations are associated with atherosclerotic cardiovascular disease The safety and efficacy of lepodisiran an extended duration small interfering RNA targeting hepa
Nonoperative Management Of Mismatch Repair Deficient Tumors
Apr 27 2025 nbsp 0183 32 Among patients with mismatch repair deficient dMMR locally advanced rectal cancer neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion of patients Whether
Overall Survival With Neoadjuvant Nivolumab Plus Chemotherapy , Jun 2 2025 nbsp 0183 32 Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event free survival in patients with resectable non small cell lung cancer NSCLC in a phase 3
Finerenone With Empagliflozin In Chronic Kidney Disease And Type
Finerenone With Empagliflozin In Chronic Kidney Disease And Type , Jun 5 2025 nbsp 0183 32 Limited evidence exists to support the simultaneous initiation of sodium glucose cotransporter 2 inhibitors and finerenone a nonsteroidal mineralocorticoid receptor antagonist in persons with
[img_title-3]
Survival Of Transplanted Allogeneic Beta Cells With No
Survival Of Transplanted Allogeneic Beta Cells With No Aug 4 2025 nbsp 0183 32 The need to suppress a patient s immune system after the transplantation of allogeneic cells is associated with wide ranging side effects We report the outcomes of transplantation of
[img_title-5]
Apr 10 2025 nbsp 0183 32 The National Academy of Medicine convened a workshop of experts and published a report that reviews the progress generative AI has achieved in health care and discusses future opportunities and cha Generative AI In Medicine Evaluating Progress And Challenges. May 11 2025 nbsp 0183 32 Tirzepatide and semaglutide are highly effective medications for obesity management The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 di Apr 28 2025 nbsp 0183 32 Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 HER2 mutant non small cell lung cancer NSCLC Zongertinib is an oral
Another Medicine Case Report Poster Presentation you can download
You can find and download another posts related to Medicine Case Report Poster Presentation by clicking link below
Thankyou for visiting and read this post about Medicine Case Report Poster Presentation